Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-18, Stock:NVS, The news for the past five days is as follows:
2018-07-11: NEWS1: Novartis Exits Antibiotics Research, Cuts 140 Jobs in Bay Area.NEWS2: Once with lofty plans, Novartis now closing East Bay unit, cutting 140 jobs.NEWS3: Removing the Hidden Obstacle Holding Back New Cancer Therapies.NEWS4: The Swiss Stock Market Dropped As Trade War Escalates.NEWS5: The Swiss Stock Market Dropped As Trade War Escalates.NEWS6: Moody's: European pharma sector earnings poised to rise into 2019 as new drugs come to market.
2018-07-12: NEWS1: Novartis To Exit Antibiotic And Antiviral Research.NEWS2: Novartis To Exit Antibiotic And Antiviral Research.NEWS3: Is Ionis Pharmaceuticals, Inc. a Buy?.NEWS4: Is Ionis Pharmaceuticals, Inc. a Buy?.NEWS5: 3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018.NEWS6: 3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018.NEWS7: 3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018.NEWS8: The Swiss Stock Market Climbed On Strength Of Pharma Heavyweights.NEWS9: The Swiss Stock Market Climbed On Strength Of Pharma Heavyweights.NEWS10: Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community.NEWS11: Novartis Launches Galaxies Of Hope App.NEWS12: Novartis Launches Galaxies Of Hope App.
2018-07-13: NEWS1: Novartis Looks to Exit Antibacterial, Antiviral Program.NEWS2: Novartis Looks to Exit Antibacterial, Antiviral Program.NEWS3: [$$] Novartis Communicated With Trump's Lawyer for Months, Report Says.NEWS4: Novartis Looks to Exit Antibacterial, Antiviral Program.NEWS5: Dems: Novartis deal with Cohen sought access to policymakers.NEWS6: Report: Ex-Trump lawyer often in touch with drug firm execs.NEWS7: Novartis Account of Cohen Connection Assailed by U.S. Senators.NEWS8: Rebound Lifts NASDAQ to New All-Time High.NEWS9: Rebound Lifts NASDAQ to New All-Time High.NEWS10: JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings?.NEWS11: JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings?.NEWS12: Better Know Biotech: Regenxbio Inc..NEWS13: Better Know Biotech: Regenxbio Inc..NEWS14: AT&T failed to provide requested documents to Senate probe of payments made to Michael Cohen.NEWS15: Novartis disputes U.S. senators' report on Cohen contract.NEWS16: JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings?.NEWS17: Cohen Pitched Novartis Russia-Tied Investment, Democrats Say.NEWS18: Cohen's Novartis Work Was Broader Than Reported, Democrats Say.NEWS19: The Swiss Stock Market Finished With Modest Gains.NEWS20: The Swiss Stock Market Finished With Modest Gains.NEWS21: Better Know Biotech: Regenxbio Inc..NEWS22: Superbugs Win Another Round as Big Pharma Leaves Antibiotics.NEWS23: [$$] Democrats allege Trump lawyer had broad contacts with Novartis.NEWS24: [$$] Democrats allege broad Novartis contacts with Trump lawyer.
2018-07-16: NEWS1: Novartis’s Q2 2018 Estimates: Innovative Medicines Business.NEWS2: Segment-Wise Expectations for Novartis in Q2 2018.NEWS3: Expectations from Novartis’s Q2 2018 Earnings.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS5: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS6: Is a Surprise in the Cards for Novartis in Q2 Earnings?.NEWS7: Is a Surprise in the Cards for Novartis in Q2 Earnings?.NEWS8: FDA Recalls Valsartan Drugs on Impurity Concerns: Teva Fell 1.8%.NEWS9: Is a Surprise in the Cards for Novartis in Q2 Earnings?.NEWS10: The Swiss Stock Market Finished Slightly Lower In Choppy Trade.NEWS11: The Swiss Stock Market Finished Slightly Lower In Choppy Trade.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS13: Novartis had ‘longer and more detailed’ relationship with Trump lawyer Michael Cohen, Senate report finds.NEWS14: This Week's Biotech IPOs.NEWS15: This Week's Biotech IPOs.
2018-07-17: NEWS1: GlaxoSmithKline Is More Than Just a 5% Dividend Income Play.NEWS2: GlaxoSmithKline Is More Than Just a 5% Dividend Income Play.NEWS3: Pre-Market Earnings Report for July 18, 2018 :  ABT, MS, ASML, USB, NVS, MTB, NTRS, ERIC, TXT, GWW, MTG, UBSH.NEWS4: Pre-Market Earnings Report for July 18, 2018 :  ABT, MS, ASML, USB, NVS, MTB, NTRS, ERIC, TXT, GWW, MTG, UBSH.NEWS5: Earnings Outlook For Novartis.NEWS6: GlaxoSmithKline Is More Than Just a 5% Dividend Income Play.NEWS7: Roche's Flu Drug Meets Primary Endpoint in Phase III Study.NEWS8: Roche's Flu Drug Meets Primary Endpoint in Phase III Study.NEWS9: Novartis’s Q2 2018 Estimates: Alcon.NEWS10: The Swiss Stock Market Pulled Back As Heavyweights Fall.NEWS11: The Swiss Stock Market Pulled Back As Heavyweights Fall.NEWS12: Novartis’s Q2 2018 Estimates: Sandoz.

Answer: Rise